The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hyperhidrosis Treatment Market Research Report 2025

Global Hyperhidrosis Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1720004

No of Pages : 86

Synopsis

In some people, the body’s mechanism for cooling itself is overactive — so overactive that they may sweat four or five times more than is necessary, or normal. When sweating is this extreme it can be embarrassing, uncomfortable, anxiety-inducing, dangerous, and disabling. It often disrupts all aspects of a person's life, from career choices and recreational activities to relationships, emotional well-being, and self-confidence. This kind of excessive sweating is a serious medical condition. It's called hyperhidrosis and it afflicts millions of people around the world (nearly 5% of the world's population). But, due to lack of awareness among sufferers and lack of education among medical professionals, most people are never diagnosed or relieved of their symptoms.

The global Hyperhidrosis Treatment market was valued at US$ 1302 million in 2023 and is anticipated to reach US$ 1921.1 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.

Global top 5 players of hyperhidrosis treatment include Allergan (AbbVie), GlaxoSmithKline, Cynosure, Journey Medical Corporation and miraDry. As the largest player, Allergan (AbbVie) makes up over a quarter.

North America ranks first in terms of market size by region, making up around 35%, followed by Europe and Asia-Pacific.

Based on the product type, the hyperhidrosis treatment is primarily split into medications, surgical treatments and physiotherapy, etc. Among them, medical is the largest segment, with a share over 45%.

Hyperhidrosis treatment is mainly used for primary focal hyperhidrosis and secondary generalized hyperhidrosis, in which the former one dominates with a share over 60%.

This report aims to provide a comprehensive presentation of the global market for Hyperhidrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperhidrosis Treatment.

Report Scope

The Hyperhidrosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hyperhidrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hyperhidrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Allergan (AbbVie)
  • GlaxoSmithKline
  • Cynosure
  • Journey Medical Corporation
  • miraDry
  • Alma Lasers
  • Carpe
  • Duradry
  • Merz Ultherapy
  • Fotona
  • BTXA
  • Seaford Pharmaceuticals
  • Robugen GmbH

Segment by Type

  • Medications
  • Surgical Treatments
  • Physiotherapy

Segment by Application

  • Primary Focal Hyperhidrosis
  • Secondary Generalized Hyperhidrosis

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hyperhidrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hyperhidrosis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medications
1.2.3 Surgical Treatments
1.2.4 Physiotherapy
1.3 Market by Application
1.3.1 Global Hyperhidrosis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Primary Focal Hyperhidrosis
1.3.3 Secondary Generalized Hyperhidrosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hyperhidrosis Treatment Market Perspective (2019-2030)
2.2 Hyperhidrosis Treatment Growth Trends by Region
2.2.1 Global Hyperhidrosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hyperhidrosis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Hyperhidrosis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Hyperhidrosis Treatment Market Dynamics
2.3.1 Hyperhidrosis Treatment Industry Trends
2.3.2 Hyperhidrosis Treatment Market Drivers
2.3.3 Hyperhidrosis Treatment Market Challenges
2.3.4 Hyperhidrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hyperhidrosis Treatment Players by Revenue
3.1.1 Global Top Hyperhidrosis Treatment Players by Revenue (2019-2024)
3.1.2 Global Hyperhidrosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Hyperhidrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hyperhidrosis Treatment Revenue
3.4 Global Hyperhidrosis Treatment Market Concentration Ratio
3.4.1 Global Hyperhidrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyperhidrosis Treatment Revenue in 2023
3.5 Hyperhidrosis Treatment Key Players Head office and Area Served
3.6 Key Players Hyperhidrosis Treatment Product Solution and Service
3.7 Date of Enter into Hyperhidrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hyperhidrosis Treatment Breakdown Data by Type
4.1 Global Hyperhidrosis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Hyperhidrosis Treatment Forecasted Market Size by Type (2025-2030)
5 Hyperhidrosis Treatment Breakdown Data by Application
5.1 Global Hyperhidrosis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Hyperhidrosis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hyperhidrosis Treatment Market Size (2019-2030)
6.2 North America Hyperhidrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hyperhidrosis Treatment Market Size by Country (2019-2024)
6.4 North America Hyperhidrosis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hyperhidrosis Treatment Market Size (2019-2030)
7.2 Europe Hyperhidrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hyperhidrosis Treatment Market Size by Country (2019-2024)
7.4 Europe Hyperhidrosis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hyperhidrosis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Hyperhidrosis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hyperhidrosis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Hyperhidrosis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hyperhidrosis Treatment Market Size (2019-2030)
9.2 Latin America Hyperhidrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hyperhidrosis Treatment Market Size by Country (2019-2024)
9.4 Latin America Hyperhidrosis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hyperhidrosis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Hyperhidrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hyperhidrosis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Hyperhidrosis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan (AbbVie)
11.1.1 Allergan (AbbVie) Company Detail
11.1.2 Allergan (AbbVie) Business Overview
11.1.3 Allergan (AbbVie) Hyperhidrosis Treatment Introduction
11.1.4 Allergan (AbbVie) Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.1.5 Allergan (AbbVie) Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Hyperhidrosis Treatment Introduction
11.2.4 GlaxoSmithKline Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Cynosure
11.3.1 Cynosure Company Detail
11.3.2 Cynosure Business Overview
11.3.3 Cynosure Hyperhidrosis Treatment Introduction
11.3.4 Cynosure Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.3.5 Cynosure Recent Development
11.4 Journey Medical Corporation
11.4.1 Journey Medical Corporation Company Detail
11.4.2 Journey Medical Corporation Business Overview
11.4.3 Journey Medical Corporation Hyperhidrosis Treatment Introduction
11.4.4 Journey Medical Corporation Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.4.5 Journey Medical Corporation Recent Development
11.5 miraDry
11.5.1 miraDry Company Detail
11.5.2 miraDry Business Overview
11.5.3 miraDry Hyperhidrosis Treatment Introduction
11.5.4 miraDry Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.5.5 miraDry Recent Development
11.6 Alma Lasers
11.6.1 Alma Lasers Company Detail
11.6.2 Alma Lasers Business Overview
11.6.3 Alma Lasers Hyperhidrosis Treatment Introduction
11.6.4 Alma Lasers Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.6.5 Alma Lasers Recent Development
11.7 Carpe
11.7.1 Carpe Company Detail
11.7.2 Carpe Business Overview
11.7.3 Carpe Hyperhidrosis Treatment Introduction
11.7.4 Carpe Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.7.5 Carpe Recent Development
11.8 Duradry
11.8.1 Duradry Company Detail
11.8.2 Duradry Business Overview
11.8.3 Duradry Hyperhidrosis Treatment Introduction
11.8.4 Duradry Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.8.5 Duradry Recent Development
11.9 Merz Ultherapy
11.9.1 Merz Ultherapy Company Detail
11.9.2 Merz Ultherapy Business Overview
11.9.3 Merz Ultherapy Hyperhidrosis Treatment Introduction
11.9.4 Merz Ultherapy Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.9.5 Merz Ultherapy Recent Development
11.10 Fotona
11.10.1 Fotona Company Detail
11.10.2 Fotona Business Overview
11.10.3 Fotona Hyperhidrosis Treatment Introduction
11.10.4 Fotona Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.10.5 Fotona Recent Development
11.11 BTXA
11.11.1 BTXA Company Detail
11.11.2 BTXA Business Overview
11.11.3 BTXA Hyperhidrosis Treatment Introduction
11.11.4 BTXA Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.11.5 BTXA Recent Development
11.12 Seaford Pharmaceuticals
11.12.1 Seaford Pharmaceuticals Company Detail
11.12.2 Seaford Pharmaceuticals Business Overview
11.12.3 Seaford Pharmaceuticals Hyperhidrosis Treatment Introduction
11.12.4 Seaford Pharmaceuticals Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.12.5 Seaford Pharmaceuticals Recent Development
11.13 Robugen GmbH
11.13.1 Robugen GmbH Company Detail
11.13.2 Robugen GmbH Business Overview
11.13.3 Robugen GmbH Hyperhidrosis Treatment Introduction
11.13.4 Robugen GmbH Revenue in Hyperhidrosis Treatment Business (2019-2024)
11.13.5 Robugen GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’